Literature DB >> 25363568

Dementia diagnostic criteria in Down syndrome.

Rory Sheehan1,2, Amanda Sinai1, Nick Bass1, Pippa Blatchford3, Ingrid Bohnen4, Simon Bonell5, Ken Courtenay1,6, Angela Hassiotis1,2, Therese Markar7, Jane McCarthy8, Kamalika Mukherji7, Asim Naeem9, Dimitrios Paschos10, Natalia Perez-Achiaga3, Vijaya Sharma11, David Thomas12, Zuzana Walker1, Andre Strydom1,10.   

Abstract

OBJECTIVE: Dementia is a common clinical presentation among older adults with Down syndrome. The presentation of dementia in Down syndrome differs compared with typical Alzheimer's disease. The performance of manualised dementia criteria in the International Classification of Diseases (ICD)-10 and Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV-TR) is uncertain in this population.We aimed to determine the concurrent validity and reliability of clinicians' diagnoses of dementia against ICD-10 and DSM-IV-TR diagnoses. Validity of clinical diagnoses were also explored by establishing the stability of diagnoses over time.
METHODS: We used clinical data from memory assessments of 85 people with Down syndrome, of whom 64 (75.3%) had a diagnosis of dementia. The cases of dementia were presented to expert raters who rated the case as dementia or no dementia using ICD-10 and DSM-IV-TR criteria and their own clinical judgement.
RESULTS: We found that clinician's judgement corresponded best with clinically diagnosed cases of dementia, identifying 84.4% cases of clinically diagnosed dementia at the time of diagnosis. ICD-10 criteria identified 70.3% cases, and DSM-IV-TR criteria identified 56.3% cases at the time of clinically diagnosed dementia. Over time, the proportion of cases meeting ICD-10 or DSM-IV-TR diagnoses increased, suggesting that experienced clinicians used their clinical knowledge of dementia presentation in Down syndrome to diagnose the disorder at an earlier stage than would have been possible had they relied on the classic description contained in the diagnostic systems.
CONCLUSIONS: Clinical diagnosis of dementia in Down syndrome is valid and reliable and can be used as the standard against which new criteria such as the DSM-5 are measured.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  DSM-IV-TR; Down syndrome; ICD-10; clinical judgement; dementia; diagnosis

Mesh:

Year:  2014        PMID: 25363568      PMCID: PMC4678599          DOI: 10.1002/gps.4228

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  14 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  Dementia and mortality in persons with Down's syndrome.

Authors:  A Coppus; H Evenhuis; G-J Verberne; F Visser; P van Gool; P Eikelenboom; C van Duijin
Journal:  J Intellect Disabil Res       Date:  2006-10

3.  Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome.

Authors:  A J Holland; J Hon; F A Huppert; F Stevens; P Watson
Journal:  Br J Psychiatry       Date:  1998-06       Impact factor: 9.319

4.  Comparison of rating scales for the diagnosis of dementia in adults with Down's syndrome.

Authors:  S Deb; J Braganza
Journal:  J Intellect Disabil Res       Date:  1999-10

5.  Dementia in people with Down's syndrome.

Authors:  J Tyrrell; M Cosgrave; M McCarron; J McPherson; J Calvert; A Kelly; M McLaughlin; M Gill; B A Lawlor
Journal:  Int J Geriatr Psychiatry       Date:  2001-12       Impact factor: 3.485

6.  Diagnostic instruments for dementia in older people with intellectual disability in clinical practice.

Authors:  A Strydom; A Hassiotis
Journal:  Aging Ment Health       Date:  2003-11       Impact factor: 3.658

7.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

Authors:  K E Wisniewski; H M Wisniewski; G Y Wen
Journal:  Ann Neurol       Date:  1985-03       Impact factor: 10.422

8.  The topography of plaques and tangles in Down's syndrome patients of different ages.

Authors:  D M Mann; P O Yates; B Marcyniuk; C R Ravindra
Journal:  Neuropathol Appl Neurobiol       Date:  1986 Sep-Oct       Impact factor: 8.090

9.  Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study.

Authors:  Sarah L Ball; Anthony J Holland; Johnny Hon; Felicia A Huppert; Peter Treppner; Peter C Watson
Journal:  Int J Geriatr Psychiatry       Date:  2006-07       Impact factor: 3.485

10.  Prevalence of dementia in intellectual disability using different diagnostic criteria.

Authors:  A Strydom; G Livingston; M King; A Hassiotis
Journal:  Br J Psychiatry       Date:  2007-08       Impact factor: 9.319

View more
  25 in total

1.  Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia.

Authors:  Sylvia E Perez; Jennifer C Miguel; Bin He; Michael Malek-Ahmadi; Eric E Abrahamson; Milos D Ikonomovic; Ira Lott; Eric Doran; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson
Journal:  Acta Neuropathol       Date:  2019-02-07       Impact factor: 17.088

2.  The AT(N) framework for Alzheimer's disease in adults with Down syndrome.

Authors:  Michael S Rafii; Beau M Ances; Nicole Schupf; Sharon J Krinsky-McHale; Mark Mapstone; Wayne Silverman; Ira Lott; William Klunk; Elizabeth Head; Brad Christian; Florence Lai; H Diana Rosas; Shahid Zaman; Melissa E Petersen; Andre Strydom; Juan Fortea; Benjamin Handen; Sid O'Bryant
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-27

3.  Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials.

Authors:  Michael S Rafii
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

4.  Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Authors:  Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

5.  Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society.

Authors:  Jean-Maurice Delabar; Bernadette Allinquant; Diana Bianchi; Tom Blumenthal; Alain Dekker; Jamie Edgin; John O'Bryan; Mara Dierssen; Marie-Claude Potier; Frances Wiseman; Faycal Guedj; Nicole Créau; Roger Reeves; Katheleen Gardiner; Jorge Busciglio
Journal:  Mol Syndromol       Date:  2016-09-16

Review 6.  Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.

Authors:  Panagiotis Zis; Andre Strydom
Journal:  Free Radic Biol Med       Date:  2017-09-01       Impact factor: 7.376

Review 7.  Pharmacological interventions for cognitive decline in people with Down syndrome.

Authors:  Nuala Livingstone; Jennifer Hanratty; Rupert McShane; Geraldine Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29

8.  The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.

Authors:  Alain D Dekker; Aurora M Ulgiati; Henk Groen; Vincent A Boxelaar; Silvia Sacco; Ségolène Falquero; Angelo Carfi; Antonella di Paola; Bessy Benejam; Silvia Valldeneu; Roelie Fopma; Marjo Oosterik; Marloes Hermelink; Gonny Beugelsdijk; Mieke Schippers; Hepie Henstra; Martine Scholten-Kuiper; Judith Willink-Vos; Lisa de Ruiter; Liesbeth Willems; Anneke Loonstra-de Jong; Antonia M W Coppus; Marleen Tollenaere; Juan Fortea; Graziano Onder; Anne-Sophie Rebillat; Debby Van Dam; Peter P De Deyn
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 9.  The neglected puzzle of dementia in people with severe/profound intellectual disabilities: A systematic literature review of observable symptoms.

Authors:  Maureen B G Wissing; Aurora M Ulgiati; Johannes S M Hobbelen; Peter P De Deyn; Aly Waninge; Alain D Dekker
Journal:  J Appl Res Intellect Disabil       Date:  2021-07-04

10.  The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population.

Authors:  Sarah E Pape; Tamara Al Janabi; Nicholas J Ashton; Abdul Hye; Rory Sheehan; Paul Gallagher; Bernice Knight; Anne-Marije Prins; Ken Courtenay; Vesna Jordanova; Bini Thomas; Nagarajan Perumal; Craig Forbes; Angela Hassiotis; Andre Strydom
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.